& Febiger, 1994, p. 317–350
8. Collins S, Kuhn CM, Petro AE, Swick AG, Chrunyk BA, Surwit RS: Role of
leptin in fat regulation (Letter). Nature 380:677, 1996
9. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI: Receptor-mediated
regional sympathetic nerve activation by leptin. J Clin Invest 100:270–278, 1997
10. Dunbar JC, Hu Y, Lu H: Intracerebroventricular leptin increases lumbar and
renal sympathetic nerve activity and blood pressure in normal rats. Diabetes
46:2040–2043, 1997
11. Pacak K, McCarty R, Palkovits M, Cizza G, Kopin IJ, Goldstein DS, Chrousos
GP: Decreased central and peripheral catecholaminergic activation in obese
Zucker rats. Endocrinology 136:4360–4367, 1995
12. Takaya K, Ogawa Y, Isse N, Okazaki T, Satoh N, Masuzaki H, Mori K, Tamura
N, Hosoda, K, Nakao K: Molecular cloning of rat leptin receptor isoform complementary DNAs: identification of a missense mutation in Zucker fatty
(fa/fa) rats. Biochem Biophys Res Commun 225:75–83, 1996
13. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S,
Lallone R, Ranganathan S, Kern PA, Friedman JM: Leptin levels in human and
rodent: measurement of plasma leptin and ob RNA in obese and weightreduced subjects. Nat Med 1:1155–1161, 1995
14. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS:
Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1:1311–1314, 1995
15. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce
MR, Ohannesian JP, Marco CC, Mckee LJ, Bauer TL, Caro JF: Serum
immunoreactive leptin concentrations in normal-weight and obese humans.
N Engl J Med 334:292–295, 1996
16. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards
GJ, Campfield LA, Clark FT, Deeds J, Muir C, Sanker S, Moriarty A, Moore KJ,
Smutko JS, Mays GG, Woolf EA, Monroe CA, Tepper RI: Identification and
expression cloning of a leptin receptor, OB-R. Cell 83:1263–1271, 1995
17. Mercer JG, Hoggard N, Williams LM, Lawrence B, Hannah LT, Trayhurn P: Localization of leptin receptor splice variant (Ob-Rb) in mouse hypothalamus and
adjacent brain regions by in situ hybridization. FEBS Lett 387:113–116, 1996
18. Fei H, Okano HJ, Li C, Lee G-H, Zhao C, Darnell R, Friedman JM: Anatomic
localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and
other tissues. Proc Natl Acad Sci U S A 94:7001–7005, 1997
19. Vaisse C, Halaas JL, Horvath CM, Darnell JE Jr, Stofell M, Friedman JM:
Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but
not in db/db mice. Nat Genet 14:95–97, 1996
20. Bjerbak C, Elmquist JK, Frantz JD, Shoelson SE, Flier JS: Identification of
SOCS-3 as a potential mediator of central leptin resistance. Mol Cell 1:
619–625, 1998
21. Woods AJ, Stock MJ: Leptin activation in hypothalamus (Letter). Nature
381:745, 1996
22. Elmquist JK, Ahima RS, Maratos-Flier E, Flier JS, Saper CB: Leptin activates
neurons in ventrobasal hypothalamus and brainstem. Endocrinology
138:839–842, 1997
23. Satoh N, Ogawa Y, Katsuura G, Tsuji T, Masuzaki H, Hiraoka J, Okazaki T,
Tamaki M, Hayase M, Yoshimasa Y, Nishi S, Hosoda K, Nakao K: Pathophysiologic significance of the obese gene product, leptin, in ventromedial hypothalamus (VMH)-lesioned rats: evidence for loss of its satiety effect in VMHlesioned rats. Endocrinology 138:947–954, 1997
24. Satoh N, Ogawa Y, Katsuura G, Hayase M, Tsuji T, Imagawa K, Yoshimasa Y,
Nishi S, Hosoda K, Nakao K: The arcuate nucleus as a primary site of satiety
effect of leptin in rats. Neurosci Lett 224:149–152, 1997
25. Gerstberger R, Kail R, Gray DA, Simon E: Arginine vasotocin and glomerular
filtration rate in saltwater-acclimated ducks. Am J Physiol 248:F663–F667, 1985
26. Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates. 2nd ed.
Sydney, Academic Press, 1986
27. Katsuura G, Arimura A, Koves K, Gottschall PE: Involvement of organum
vasculosum of lamina terminalis and preoptic area in interleukin-1β–induced
ACTH release. Am J Physiol 258:E163–E171, 1990
28. Saller CF, Salama AI: Rapid automated analysis of biogenic amines and their
metabolites using reversed-phase high-performance liquid chromatography
with electrochemical detection. J Chromatography 309:287–298, 1984
29. van Dijk G, Donahey JCK, Thiele TE, Scheurink AJW, Stefens AB, Wilkinson
CW, Tenenbaum R, Campfield LA, Burn P, Seeley RJ, Woods SC: Central leptin stimulates corticosterone secretion at the onset of the dark phase. Diabetes
46:1911–1914, 1997
30. Agata J, Masuda A, Higashiura K, Murakami H, Miyazaki Y, Shimamoto K:
High plasma immunoreactive leptin level in essential hypertension. Am J
Hypertension 10:1171–1174, 1997
31. Ogawa Y, Masuzaki H, Aizawa M, Yura S, Satoh N, Iwai H, Hosoda K, Nakao
K: Blood pressure elevation in transgenic mice overexpressing leptin, the obese
gene product (Abstract). J Hypertens 16 (Suppl. 2):S7, 1998
